Fennec Pharmaceuticals's total assets for Q1 2026 were $71.64M, an increase of 2.24% from the previous quarter. FENC total liabilities were $34.06M for the fiscal quarter, a -2.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.